• Find people
• Intranet

News

01/12/2022 - General information

STOPSTORM Registry Opening

The first EU-wide STAR treatment registry is now open! STOPSTORM is now accepting anonymized data from our 30 partner organizations across 8 European countries. Later, we will expand this to even more centers across the EU. STOPSTORM aims to collect data from over 300 patients into the registry by 2025. These data will establish the indication, safety and efficacy of STAR for the treatment for Ventricular Tachycardia.

What is STAR treatment? STAR is a non-invasive radiotherapy technique used to treat dangerously fast heart rhythm, called ventricular tachycardia, or VT. A similar radiotherapy technique has been used for a decade to treat lung cancer. Application of STAR for use in VT is relatively new, and while early results are promising, there is still more to learn about the longer-term effects of the treatment. Therefore, STOPSTORM has created an EU-wide database to better understand the safety and efficacy of the treatment.

Learn more about the STAR treatment in this short animation: https://youtu.be/rmyJvGgL0Og

This project has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement no. 945119.

More news